Why NeOnc NTHI is still under the radar Institutional Selling 20260511 ODD ODDITY delivers a strong Q4 2025 EPS beat shares notch a 168 percent gain on positive investor sentiment What risks should investors watch for Esperion Therapeutics ESPR stock 270 20260420 BHFAP Bright Pfd A Q1 earnings miss estimates by 75 yet shares rise 04 despite disappointment Gilead Sciences GILD Arcus Pipeline Restructuring and Emerging HIV Competitive Risks Reshape Investment Thesis POCI Q1 2026 Earnings Narrowing Loss Amidst Operational Progress CTSH Q1 2026 Earnings EPS Surprises to the Upside Shares Edge Higher GXO Logistics Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gain PENN Q1 2026 Earnings EPS Misses Estimates as Margins Remain Under Pressure RRR Q1 2026 Earnings EPS Surpasses Estimates Stock Rises 377 MDV Q1 2026 Earnings Industrial REIT Reports Deep Earnings Miss as Losses Sharply Exceed Estimates